Form 4: Nanophase Technologies Director Janet Whitmore Acquires Additional Shares
SEC Form 4 Filing
Director Janet Whitmore of Nanophase Technologies Corp. [NANX] recently purchased additional shares of common stock, increasing her total holdings.
Summary
- On September 3, 2024, Janet Whitmore, a director of Nanophase Technologies Corp. [NANX], acquired 100 shares of common stock at $1.47 per share and 144 shares at $1.48 per share.
- On September 4, 2024, she acquired an additional 9,019 shares at $1.50 per share.
- Following these transactions, Whitmore directly owns 1,947,221 shares of Nanophase Technologies Corp.
- Whitmore also holds derivative securities, including options to purchase common stock at various exercise prices and deferred common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's purchase suggests confidence, but the scale of the purchase is relatively small.
Positives
- The director's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Director share purchases are common and closely watched as indicators of management's sentiment about the company's prospects. It is a small purchase.
Comparison to Industry Standards
- Comparing Janet Whitmore's transactions to similar filings by directors in comparable small-cap technology firms reveals that such purchases are not uncommon.
- However, the significance of the purchase depends on the size of the transaction relative to her existing holdings and the company's market capitalization.
- Without more context on Nanophase's financial performance and strategic direction, it's difficult to assess whether this purchase is more or less significant than similar transactions in the industry.
Stakeholder Impact
- The director's purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/17/2016 | Date of grant for several stock appreciation rights (later converted to options) with various exercise prices and expiration on 11/17/2026. |
| 02/21/2018 | Date of grant for stock options with an exercise price of $0.68, expiring on 02/21/2027. |
| 05/23/2019 | Date of grant for stock options with an exercise price of $0.82, expiring on 05/23/2028. |
| 06/18/2021 | Date of grant for stock options with an exercise price of $0.45, expiring on 06/18/2027. |
| 12/28/2022 | Date of grant for stock options with an exercise price of $4.17, expiring on 12/28/2028. |
| 12/20/2023 | Date of grant for stock options with an exercise price of $1.165, expiring on 12/20/2029. |
| 09/03/2024 | Janet Whitmore purchased 100 shares of common stock at $1.47 and 144 shares at $1.48. |
| 09/04/2024 | Janet Whitmore purchased 9,019 shares of common stock at $1.50. |
| 12/27/2024 | Date of grant for stock options with an exercise price of $0.61, expiring on 12/27/2030. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.